Abstract
Since its re-emergence in 2006, Chikungunya has been a major health concern in endemic areas. Transmitted by Aedes mosquitoes to mammalian hosts, Chikungunya leads to persistent debilitating symptoms in a high proportion of symptomatic human cases. In this review, we present several tools on the mosquito vector side as well as on the mammalian side that have been used to advance research on Chikungunya transmission and immunopathogenesis. These tools lead to key understandings of viral replication in both hosts, and innate and adaptive responses mediating virus clearance and pathology in mammals. This comprehension of viral mechanisms has allowed the development of promising treatment avenues in animal models that will need to be further explored. However, research efforts need to continue in order to develop better and unbiased tools to assess antiviral and treatment strategies as well as further understand immune mechanisms at play in human pathologies.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahola T, Karlin DG (2015) Sequence analysis reveals a conserved extension in the capping enzyme of the alphavirus supergroup, and a homologous domain in nodaviruses. Biol Direct 10:16. https://doi.org/10.1186/s13062-015-0050-0
Akhrymuk I, Kulemzin SV, Frolova EI (2012) Evasion of the innate immune response: the Old World alphavirus nsP2 protein induces rapid degradation of Rpb1, a catalytic subunit of RNA polymerase II. J Virol 86(13):7180–7191. https://doi.org/10.1128/JVI.00541-12
Arankalle VA, Shrivastava S, Cherian S, Gunjikar RS, Walimbe AM, Jadhav SM, Sudeep AB, Mishra AC (2007) Genetic divergence of Chikungunya viruses in India (1963–2006) with special reference to the 2005–2006 explosive epidemic. J Gen Virol 88(Pt 7):1967–1976. https://doi.org/10.1099/vir.0.82714-0
Atkins GJ (2013) The pathogenesis of alphaviruses. ISRN. Virology 2013:22. https://doi.org/10.5402/2013/861912
Balakrishna Pillai A, Nagarajan U, Mitra A, Krishnan U, Rajendran S, Hoti SL, Mishra RK (2017) RNA interference in mosquito: understanding immune responses, double-stranded RNA delivery systems and potential applications in vector control. Insect Mol Biol 26(2):127–139. https://doi.org/10.1111/imb.12282
Bernhardt SA, Simmons MP, Olson KE, Beaty BJ, Blair CD, Black WC (2012) Rapid intraspecific evolution of miRNA and siRNA genes in the mosquito Aedes aegypti. PLoS ONE 7(9):e44198. https://doi.org/10.1371/journal.pone.0044198
Blair CD (2011) Mosquito RNAi is the major innate immune pathway controlling arbovirus infection and transmission. Future Microbiol 6(3):265–277. https://doi.org/10.2217/fmb.11.11
Borgherini G, Poubeau P, Jossaume A, Gouix A, Cotte L, Michault A, Arvin-Berod C, Paganin F (2008) Persistent arthralgia associated with Chikungunya virus: a study of 88 adult patients on reunion island. Clin Infect Dis 47(4):469–475. https://doi.org/10.1086/590003
Bourai M, Lucas-Hourani M, Gad HH, Drosten C, Jacob Y, Tafforeau L, Cassonnet P, Jones LM, Judith D, Couderc T, Lecuit M, Andre P, Kummerer BM, Lotteau V, Despres P, Tangy F, Vidalain PO (2012) Mapping of Chikungunya virus interactions with host proteins identified nsP2 as a highly connected viral component. J Virol 86(6):3121–3134. https://doi.org/10.1128/JVI.06390-11
Brackney DE, Scott JC, Sagawa F, Woodward JE, Miller NA, Schilkey FD, Mudge J, Wilusz J, Olson KE, Blair CD, Ebel GD (2010) C6/36 Aedes albopictus cells have a dysfunctional antiviral RNA interference response. PLoS Negl Trop Dis 4(10):e856. https://doi.org/10.1371/journal.pntd.0000856
Broeckel R, Haese N, Messaoudi I, Streblow DN (2015) Nonhuman primate models of Chikungunya virus infection and disease (CHIKV NHP Model). Pathogens 4(3):662–681. https://doi.org/10.3390/pathogens4030662
Burt FJ, Chen W, Miner JJ, Lenschow DJ, Merits A, Schnettler E, Kohl A, Rudd PA, Taylor A, Herrero LJ, Zaid A, Ng LFP, Mahalingam S (2017) Chikungunya virus: an update on the biology and pathogenesis of this emerging pathogen. Lancet Infect Dis 17(4):e107–e117. https://doi.org/10.1016/S1473-3099(16)30385-1
Carey DE (1971) Chikungunya and dengue: a case of mistaken identity? J Hist Med Allied Sci 26(3):243–262
Carissimo G, Pondeville E, McFarlane M, Dietrich I, Mitri C, Bischoff E, Antoniewski C, Bourgouin C, Failloux AB, Kohl A, Vernick KD (2015) Antiviral immunity of Anopheles gambiae is highly compartmentalized, with distinct roles for RNA interference and gut microbiota. Proc Natl Acad Sci U S A 112(2):E176–E185. https://doi.org/10.1073/pnas.1412984112
Chen CI, Clark DC, Pesavento P, Lerche NW, Luciw PA, Reisen WK, Brault AC (2010) Comparative pathogenesis of epidemic and enzootic Chikungunya viruses in a pregnant Rhesus macaque model. Am J Trop Med Hyg 83(6):1249–1258. https://doi.org/10.4269/ajtmh.2010.10-0290
Chen W, Foo SS, Taylor A, Lulla A, Merits A, Hueston L, Forwood MR, Walsh NC, Sims NA, Herrero LJ, Mahalingam S (2015) Bindarit, an inhibitor of monocyte chemotactic protein synthesis, protects against bone loss induced by Chikungunya virus infection. J Virol 89(1):581–593. https://doi.org/10.1128/JVI.02034-14
Chen W, Foo SS, Zaid A, Teng TS, Herrero LJ, Wolf S, Tharmarajah K, Vu LD, van Vreden C, Taylor A, Freitas JR, Li RW, Woodruff TM, Gordon R, Ojcius DM, Nakaya HI, Kanneganti TD, O’Neill LAJ, Robertson AAB, King NJ, Suhrbier A, Cooper MA, Ng LFP, Mahalingam S (2017) Specific inhibition of NLRP3 in Chikungunya disease reveals a role for inflammasomes in alphavirus-induced inflammation. Nat Microbiol. https://doi.org/10.1038/s41564-017-0015-4
Cirimotich CM, Scott JC, Phillips AT, Geiss BJ, Olson KE (2009) Suppression of RNA interference increases alphavirus replication and virus-associated mortality in Aedes aegypti mosquitoes. BMC Microbiol 9:49. https://doi.org/10.1186/1471-2180-9-49
Cook SH, Griffin DE (2003) Luciferase imaging of a neurotropic viral infection in intact animals. J Virol 77 (9):5333–5338
Cordel H, Quatresous I, Paquet C, Couturier E (2006) Imported cases of Chikungunya in metropolitan France, April 2005–February 2006. Euro Surveill 11 (4):E060420 060423
Couderc T, Chretien F, Schilte C, Disson O, Brigitte M, Guivel-Benhassine F, Touret Y, Barau G, Cayet N, Schuffenecker I, Despres P, Arenzana-Seisdedos F, Michault A, Albert ML, Lecuit M (2008) A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease. PLoS Pathog 4(2):e29. https://doi.org/10.1371/journal.ppat.0040029
Das PK, Merits A, Lulla A (2014) Functional cross-talk between distant domains of Chikungunya virus non-structural protein 2 is decisive for its RNA-modulating activity. J Biol Chem 289(9):5635–5653. https://doi.org/10.1074/jbc.M113.503433
Diallo M, Dia I, Diallo D, Diagne CT, Ba Y, Yactayo S (2016) Perspectives and challenges in entomological risk assessment and vector control of Chikungunya. J Infect Dis 214(suppl 5):S459–S465. https://doi.org/10.1093/infdis/jiw397
Dietrich I, Shi X, McFarlane M, Watson M, Blomstrom AL, Skelton JK, Kohl A, Elliott RM, Schnettler E (2017) The antiviral RNAi response in vector and non-vector cells against Orthobunyaviruses. PLoS Negl Trop Dis 11(1):e0005272. https://doi.org/10.1371/journal.pntd.0005272
Dubrulle M, Mousson L, Moutailler S, Vazeille M, Failloux AB (2009) Chikungunya virus and Aedes mosquitoes: saliva is infectious as soon as two days after oral infection. PLoS ONE 4(6):e5895. https://doi.org/10.1371/journal.pone.0005895
Frolov I, Frolova E, Schlesinger S (1997) Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA. J Virol 71(4):2819–2829
Fros JJ, Geertsema C, Zouache K, Baggen J, Domeradzka N, van Leeuwen DM, Flipse J, Vlak JM, Failloux AB, Pijlman GP (2015a) Mosquito Rasputin interacts with Chikungunya virus nsP3 and determines the infection rate in Aedes albopictus. Parasit Vectors 8:464. https://doi.org/10.1186/s13071-015-1070-4
Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP (2010) Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. J Virol 84(20):10877–10887. https://doi.org/10.1128/JVI.00949-10
Fros JJ, Major LD, Scholte FE, Gardner J, van Hemert MJ, Suhrbier A, Pijlman GP (2015b) Chikungunya virus non-structural protein 2-mediated host shut-off disables the unfolded protein response. J Gen Virol 96(Pt 3):580–589. https://doi.org/10.1099/vir.0.071845-0
Fros JJ, van der Maten E, Vlak JM, Pijlman GP (2013) The C-terminal domain of Chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling. J Virol 87(18):10394–10400. https://doi.org/10.1128/JVI.00884-13
Gardner CL, Burke CW, Higgs ST, Klimstra WB, Ryman KD (2012) Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type Chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate. Virology 425(2):103–112. https://doi.org/10.1016/j.virol.2011.12.020
Gerardin P, Fianu A, Malvy D, Mussard C, Boussaid K, Rollot O, Michault A, Gauzere BA, Breart G, Favier F (2011) Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study. BMC Med 9:5. https://doi.org/10.1186/1741-7015-9-5
Goertz GP, Vogels CBF, Geertsema C, Koenraadt CJM, Pijlman GP (2017) Mosquito co-infection with Zika and Chikungunya virus allows simultaneous transmission without affecting vector competence of Aedes aegypti. PLoS Negl Trop Dis 11(6):e0005654. https://doi.org/10.1371/journal.pntd.0005654
Haese NN, Broeckel RM, Hawman DW, Heise MT, Morrison TE, Streblow DN (2016) Animal models of Chikungunya virus infection and disease. J Infect Dis 214(suppl 5):S482–S487. https://doi.org/10.1093/infdis/jiw284
Halstead SB (2015) Reappearance of chikungunya, formerly called dengue, in the Americas. Emerg Infect Dis 21(4):557–561. https://doi.org/10.3201/eid2104.141723
Hapuarachchi HC, Bandara KB, Sumanadasa SD, Hapugoda MD, Lai YL, Lee KS, Tan LK, Lin RT, Ng LF, Bucht G, Abeyewickreme W, Ng LC (2010) Re-emergence of Chikungunya virus in South-east Asia: virological evidence from Sri Lanka and Singapore. J Gen Virol 91(Pt 4):1067–1076. https://doi.org/10.1099/vir.0.015743-0
Hardy JL, Houk EJ, Kramer LD, Reeves WC (1983) Intrinsic factors affecting vector competence of mosquitoes for arboviruses. Annu Rev Entomol 28:229–262. https://doi.org/10.1146/annurev.en.28.010183.001305
Hawman DW, Stoermer KA, Montgomery SA, Pal P, Oko L, Diamond MS, Morrison TE (2013) Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol 87(24):13878–13888. https://doi.org/10.1128/JVI.02666-13
Hellstrom K, Kallio K, Utt A, Quirin T, Jokitalo E, Merits A, Ahola T (2017) Partially uncleaved alphavirus replicase forms spherule structures in the presence and absence of RNA template. J Virol 91(18). https://doi.org/10.1128/jvi.00787-17
Her Z, Teng TS, Tan JJ, Teo TH, Kam YW, Lum FM, Lee WW, Gabriel C, Melchiotti R, Andiappan AK, Lulla V, Lulla A, Win MK, Chow A, Biswas SK, Leo YS, Lecuit M, Merits A, Renia L, Ng LF (2015) Loss of TLR3 aggravates CHIKV replication and pathology due to an altered virus-specific neutralizing antibody response. EMBO Mol Med 7(1):24–41. https://doi.org/10.15252/emmm.201404459
Hoarau JJ, Jaffar Bandjee MC, Krejbich Trotot P, Das T, Li-Pat-Yuen G, Dassa B, Denizot M, Guichard E, Ribera A, Henni T, Tallet F, Moiton MP, Gauzere BA, Bruniquet S, Jaffar Bandjee Z, Morbidelli P, Martigny G, Jolivet M, Gay F, Grandadam M, Tolou H, Vieillard V, Debre P, Autran B, Gasque P (2010) Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response. J Immunol 184(10):5914–5927. https://doi.org/10.4049/jimmunol.0900255
Igarashi A (1978) Isolation of a Singh’s Aedes albopictus cell clone sensitive to Dengue and Chikungunya viruses. J Gen Virol 40(3):531–544. https://doi.org/10.1099/0022-1317-40-3-531
Jones PH, Maric M, Madison MN, Maury W, Roller RJ, Okeoma CM (2013) BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology 438(1):37–49. https://doi.org/10.1016/j.virol.2013.01.010
Josseran L, Paquet C, Zehgnoun A, Caillere N, Le Tertre A, Solet JL, Ledrans M (2006) Chikungunya disease outbreak, Reunion Island. Emerg Infect Dis 12(12):1994–1995. https://doi.org/10.3201/eid1212.060710
Judith D, Mostowy S, Bourai M, Gangneux N, Lelek M, Lucas-Hourani M, Cayet N, Jacob Y, Prevost MC, Pierre P, Tangy F, Zimmer C, Vidalain PO, Couderc T, Lecuit M (2013) Species-specific impact of the autophagy machinery on Chikungunya virus infection. EMBO Rep 14(6):534–544. https://doi.org/10.1038/embor.2013.51
Kalantri SP, Joshi R, Riley LW (2006) Chikungunya epidemic: an Indian perspective. Natl Med J India 19(6):315–322
Karlas A, Berre S, Couderc T, Varjak M, Braun P, Meyer M, Gangneux N, Karo-Astover L, Weege F, Raftery M, Schonrich G, Klemm U, Wurzlbauer A, Bracher F, Merits A, Meyer TF, Lecuit M (2016) A human genome-wide loss-of-function screen identifies effective Chikungunya antiviral drugs. Nat Commun 7:11320. https://doi.org/10.1038/ncomms11320
Karpe YA, Aher PP, Lole KS (2011) NTPase and 5’-RNA triphosphatase activities of Chikungunya virus nsP2 protein. PLoS ONE 6(7):e22336. https://doi.org/10.1371/journal.pone.0022336
Keene KM, Foy BD, Sanchez-Vargas I, Beaty BJ, Blair CD, Olson KE (2004) RNA interference acts as a natural antiviral response to O’nyong-nyong virus (Alphavirus; Togaviridae) infection of Anopheles gambiae. Proc Natl Acad Sci U S A 101(49):17240–17245. https://doi.org/10.1073/pnas.0406983101
Khoo CC, Doty JB, Heersink MS, Olson KE, Franz AW (2013) Transgene-mediated suppression of the RNA interference pathway in Aedes aegypti interferes with gene silencing and enhances Sindbis virus and dengue virus type 2 replication. Insect Mol Biol 22(1):104–114. https://doi.org/10.1111/imb.12008
Khoo CC, Piper J, Sanchez-Vargas I, Olson KE, Franz AW (2010) The RNA interference pathway affects midgut infection- and escape barriers for Sindbis virus in Aedes aegypti. BMC Microbiol 10:130. https://doi.org/10.1186/1471-2180-10-130
Kramer LD, Ciota AT (2015) Dissecting vectorial capacity for mosquito-borne viruses. Curr Opin Virol 15:112–118. https://doi.org/10.1016/j.coviro.2015.10.003
Kuhn R (2007) Togaviridae: the viruses and their replication. In: Knipe DMHP (ed) Fields’ Virology, 5th edn. Lippincott, Williams and Wilkins, NY, USA, pp 1001–1022
Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, Guigand L, Dubreil L, Lebon P, Verrier B, de Lamballerie X, Suhrbier A, Cherel Y, Le Grand R, Roques P (2010) Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 120(3):894–906. https://doi.org/10.1172/JCI40104
Lambrechts L, Quillery E, Noel V, Richardson JH, Jarman RG, Scott TW, Chevillon C (2013) Specificity of resistance to dengue virus isolates is associated with genotypes of the mosquito antiviral gene Dicer-2. Proc Biol Sci 280(1751):20122437. https://doi.org/10.1098/rspb.2012.2437
Lanciotti RS, Valadere AM (2014) Transcontinental movement of Asian genotype Chikungunya virus. Emerg Infect Dis 20(8):1400–1402. https://doi.org/10.3201/eid2008.140268
Le Coupanec A, Tchankouo-Nguetcheu S, Roux P, Khun H, Huerre M, Morales-Vargas R, Enguehard M, Lavillette D, Misse D, Choumet V (2017) Co-infection of mosquitoes with Chikungunya and dengue viruses reveals modulation of the replication of both viruses in midguts and salivary glands of Aedes aegypti mosquitoes. Int J Mol Sci 18(8). https://doi.org/10.3390/ijms18081708
Lee WW, Teo TH, Her Z, Lum FM, Kam YW, Haase D, Renia L, Rotzschke O, Ng LF (2015) Expanding regulatory T cells alleviates Chikungunya virus-induced pathology in mice. J Virol. https://doi.org/10.1128/jvi.00998-15
Lemant J, Boisson V, Winer A, Thibault L, Andre H, Tixier F, Lemercier M, Antok E, Cresta MP, Grivard P, Besnard M, Rollot O, Favier F, Huerre M, Campinos JL, Michault A (2008) Serious acute Chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005–2006. Crit Care Med 36(9):2536–2541. https://doi.org/10.1097/CCM.0b013e318183f2d2
Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X (2014) Chikungunya in the Americas. Lancet 383(9916):514. https://doi.org/10.1016/S0140-6736(14)60185-9
Lounibos LP, Kramer LD (2016) Invasiveness of Aedes aegypti and Aedes albopictus and vectorial capacity for Chikungunya virus. J Infect Dis 214(suppl 5):S453–S458. https://doi.org/10.1093/infdis/jiw285
Lulla A, Lulla V, Merits A (2012) Macromolecular assembly-driven processing of the 2/3 cleavage site in the alphavirus replicase polyprotein. J Virol 86(1):553–565. https://doi.org/10.1128/JVI.05195-11
Lulla V, Karo-Astover L, Rausalu K, Merits A, Lulla A (2013) Presentation overrides specificity: probing the plasticity of alphaviral proteolytic activity through mutational analysis. J Virol 87(18):10207–10220. https://doi.org/10.1128/JVI.01485-13
Lum FM, Teo TH, Lee WW, Kam YW, Renia L, Ng LF (2013) An essential role of antibodies in the control of Chikungunya virus infection. J Immunol 190(12):6295–6302. https://doi.org/10.4049/jimmunol.1300304
Lumsden WH (1955) An epidemic of virus disease in Southern province, Tanganyika territory, in 1952–53. II. General description and epidemiology. Trans R Soc Trop Med Hyg 49(1):33–57
Mahauad-Fernandez WD, Jones PH, Okeoma CM (2014) Critical role for bone marrow stromal antigen 2 in acute Chikungunya virus infection. J Gen Virol 95(Pt 11):2450–2461. https://doi.org/10.1099/vir.0.068643-0
Malet H, Coutard B, Jamal S, Dutartre H, Papageorgiou N, Neuvonen M, Ahola T, Forrester N, Gould EA, Lafitte D, Ferron F, Lescar J, Gorbalenya AE, de Lamballerie X, Canard B (2009) The crystal structures of Chikungunya and Venezuelan equine encephalitis virus nsP3 macro domains define a conserved adenosine binding pocket. J Virol 83(13):6534–6545. https://doi.org/10.1128/JVI.00189-09
Marimoutou C, Vivier E, Oliver M, Boutin JP, Simon F (2012) Morbidity and impaired quality of life 30 months after Chikungunya infection: comparative cohort of infected and uninfected French military policemen in Reunion Island. Medicine (Baltimore) 91(4):212–219. https://doi.org/10.1097/MD.0b013e318260b604
Mathur K, Anand A, Dubey SK, Sanan-Mishra N, Bhatnagar RK, Sunil S (2016) Analysis of Chikungunya virus proteins reveals that non-structural proteins nsP2 and nsP3 exhibit RNA interference (RNAi) suppressor activity. Sci Rep 6:38065. https://doi.org/10.1038/srep38065
McFarlane M, Arias-Goeta C, Martin E, O’Hara Z, Lulla A, Mousson L, Rainey SM, Misbah S, Schnettler E, Donald CL, Merits A, Kohl A, Failloux AB (2014) Characterization of Aedes aegypti innate-immune pathways that limit Chikungunya virus replication. PLoS Negl Trop Dis 8(7):e2994. https://doi.org/10.1371/journal.pntd.0002994
Messaoudi I, Vomaske J, Totonchy T, Kreklywich CN, Haberthur K, Springgay L, Brien JD, Diamond MS, Defilippis VR, Streblow DN (2013) Chikungunya virus infection results in higher and persistent viral replication in aged rhesus macaques due to defects in anti-viral immunity. PLoS Negl Trop Dis 7(7):e2343. https://doi.org/10.1371/journal.pntd.0002343
Miller JR, Koren S, Dilley KA, Puri V, Brown DM, Harkins DM, Thibaud-Nissen F, Rosen B, Chen X-G, Tu Z, Sharakhov IV, Sharakhova MV, Sebra R, Stockwell TB, Bergman NH, Sutton GG, Phillippy AM, Piermarini PM, Shabman RS (2017) Analysis of the <em> Aedes albopictus </em > C6/36 genome provides insight into cell line adaptations to < em > in vitro </em> viral propagation. bioRxiv. https://doi.org/10.1101/157081
Miner JJ, Aw-Yeang HX, Fox JM, Taffner S, Malkova ON, Oh ST, Kim AHJ, Diamond MS, Lenschow DJ, Yokoyama WM (2015) Chikungunya viral arthritis in the United States: a mimic of seronegative rheumatoid arthritis. Arthritis Rheumatol 67(5):1214–1220. https://doi.org/10.1002/art.39027
Nunes MR, Faria NR, de Vasconcelos JM, Golding N, Kraemer MU, de Oliveira LF, Azevedo Rdo S, da Silva DE, da Silva EV, da Silva SP, Carvalho VL, Coelho GE, Cruz AC, Rodrigues SG, Vianez JL Jr, Nunes BT, Cardoso JF, Tesh RB, Hay SI, Pybus OG, Vasconcelos PF (2015) Emergence and potential for spread of Chikungunya virus in Brazil. BMC Med 13:102. https://doi.org/10.1186/s12916-015-0348-x
Olagnier D, Scholte FE, Chiang C, Albulescu IC, Nichols C, He Z, Lin R, Snijder EJ, van Hemert MJ, Hiscott J (2014) Inhibition of dengue and Chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol 88(8):4180–4194. https://doi.org/10.1128/JVI.03114-13
Olson KE, Blair CD (2015) Arbovirus-mosquito interactions: RNAi pathway. Curr Opin Virol 15:119–126. https://doi.org/10.1016/j.coviro.2015.10.001
Olson KE, Higgs S, Hahn CS, Rice CM, Carlson JO, Beaty BJ (1994) The expression of chloramphenicol acetyltransferase in Aedes albopictus (C6/36) cells and Aedes triseriatus mosquitoes using a double subgenomic recombinant Sindbis virus. Insect Biochem Mol Biol 24(1):39–48
Ooi YS, Stiles KM, Liu CY, Taylor GM, Kielian M (2013) Genome-wide RNAi screen identifies novel host proteins required for alphavirus entry. PLoS Pathog 9(12):e1003835. https://doi.org/10.1371/journal.ppat.1003835
Panas MD, Ahola T, McInerney GM (2014) The C-terminal repeat domains of nsP3 from the Old World alphaviruses bind directly to G3BP. J Virol 88(10):5888–5893. https://doi.org/10.1128/JVI.00439-14
Panda D, Rose PP, Hanna SL, Gold B, Hopkins KC, Lyde RB, Marks MS, Cherry S (2013) Genome-wide RNAi screen identifies SEC61A and VCP as conserved regulators of Sindbis virus entry. Cell Rep 5(6):1737–1748. https://doi.org/10.1016/j.celrep.2013.11.028
Phillips A, Mossel E, Sanchez-Vargas I, Foy B, Olson K (2010) Alphavirus transducing system: tools for visualizing infection in mosquito vectors. J Vis Exp (45). https://doi.org/10.3791/2363
Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M (2007) Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7(5):319–327. https://doi.org/10.1016/S1473-3099(07)70107-X
Pierro DJ, Myles KM, Foy BD, Beaty BJ, Olson KE (2003) Development of an orally infectious Sindbis virus transducing system that efficiently disseminates and expresses green fluorescent protein in Aedes aegypti. Insect Mol Biol 12(2):107–116
Poo YS, Nakaya H, Gardner J, Larcher T, Schroder WA, Le TT, Major LD, Suhrbier A (2014a) CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated Chikungunya virus arthritis. J Virol 88(12):6862–6872. https://doi.org/10.1128/JVI.03364-13
Poo YS, Rudd PA, Gardner J, Wilson JA, Larcher T, Colle MA, Le TT, Nakaya HI, Warrilow D, Allcock R, Bielefeldt-Ohmann H, Schroder WA, Khromykh AA, Lopez JA, Suhrbier A (2014b) Multiple immune factors are involved in controlling acute and chronic Chikungunya virus infection. PLoS Negl Trop Dis 8(12):e3354. https://doi.org/10.1371/journal.pntd.0003354
Powers AM, Brault AC, Shirako Y, Strauss EG, Kang W, Strauss JH, Weaver SC (2001) Evolutionary relationships and systematics of the alphaviruses. J Virol 75(21):10118–10131. https://doi.org/10.1128/JVI.75.21.10118-10131.2001
Powers AM, Brault AC, Tesh RB, Weaver SC (2000) Re-emergence of Chikungunya and O’nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 81(Pt 2):471–479. https://doi.org/10.1099/0022-1317-81-2-471
Priya R, Patro IK, Parida MM (2014) TLR3 mediated innate immune response in mice brain following infection with Chikungunya virus. Virus Res 189:194–205. https://doi.org/10.1016/j.virusres.2014.05.010
Pushko P, Geisbert J, Parker M, Jahrling P, Smith J (2001) Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses. J Virol 75(23):11677–11685. https://doi.org/10.1128/JVI.75.23.11677-11685.2001
Rajapakse S, Rodrigo C, Rajapakse A (2010) Atypical manifestations of Chikungunya infection. Trans R Soc Trop Med Hyg 104(2):89–96. https://doi.org/10.1016/j.trstmh.2009.07.031
Rathore AP, Ng ML, Vasudevan SG (2013) Differential unfolded protein response during Chikungunya and Sindbis virus infection: CHIKV nsP4 suppresses eIF2alpha phosphorylation. Virol J 10:36. https://doi.org/10.1186/1743-422X-10-36
Rayner JO, Dryga SA, Kamrud KI (2002) Alphavirus vectors and vaccination. Rev Med Virol 12(5):279–296. https://doi.org/10.1002/rmv.360
Renault P, Solet JL, Sissoko D, Balleydier E, Larrieu S, Filleul L, Lassalle C, Thiria J, Rachou E, de Valk H, Ilef D, Ledrans M, Quatresous I, Quenel P, Pierre V (2007) A major epidemic of Chikungunya virus infection on Reunion Island, France, 2005–2006. Am J Trop Med Hyg 77(4):727–731
Rezza G, Nicoletti L, Angelini R, Romi R, Finarelli AC, Panning M, Cordioli P, Fortuna C, Boros S, Magurano F, Silvi G, Angelini P, Dottori M, Ciufolini MG, Majori GC, Cassone A, group Cs (2007) Infection with Chikungunya virus in Italy: an outbreak in a temperate region. Lancet 370 (9602):1840–1846. https://doi.org/10.1016/s0140-6736(07)61779-6
Rice CM, Levis R, Strauss JH, Huang HV (1987) Production of infectious RNA transcripts from Sindbis virus cDNA clones: mapping of lethal mutations, rescue of a temperature-sensitive marker, and in vitro mutagenesis to generate defined mutants. J Virol 61(12):3809–3819
Robinson MC (1955) An epidemic of virus disease in Southern Province, Tanganyika Territory, in 1952–53. I. Clinical features. Trans R Soc Trop Med Hyg 49 (1):28–32
Rudd PA, Wilson J, Gardner J, Larcher T, Babarit C, Le TT, Anraku I, Kumagai Y, Loo YM, Gale M Jr, Akira S, Khromykh AA, Suhrbier A (2012) Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. J Virol 86(18):9888–9898. https://doi.org/10.1128/JVI.00956-12
Schilte C, Buckwalter MR, Laird ME, Diamond MS, Schwartz O, Albert ML (2012) Cutting edge: independent roles for IRF-3 and IRF-7 in hematopoietic and nonhematopoietic cells during host response to Chikungunya infection. J Immunol 188(7):2967–2971. https://doi.org/10.4049/jimmunol.1103185
Schilte C, Couderc T, Chretien F, Sourisseau M, Gangneux N, Guivel-Benhassine F, Kraxner A, Tschopp J, Higgs S, Michault A, Arenzana-Seisdedos F, Colonna M, Peduto L, Schwartz O, Lecuit M, Albert ML (2010) Type I IFN controls Chikungunya virus via its action on nonhematopoietic cells. J Exp Med 207(2):429–442. https://doi.org/10.1084/jem.20090851
Schilte C, Staikowsky F, Couderc T, Madec Y, Carpentier F, Kassab S, Albert ML, Lecuit M, Michault A (2013) Chikungunya virus-associated long-term arthralgia: a 36-month prospective longitudinal study. PLoS Negl Trop Dis 7(3):e2137. https://doi.org/10.1371/journal.pntd.0002137
Schuffenecker I, Iteman I, Michault A, Murri S, Frangeul L, Vaney MC, Lavenir R, Pardigon N, Reynes JM, Pettinelli F, Biscornet L, Diancourt L, Michel S, Duquerroy S, Guigon G, Frenkiel MP, Brehin AC, Cubito N, Despres P, Kunst F, Rey FA, Zeller H, Brisse S (2006) Genome microevolution of Chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3(7):e263. https://doi.org/10.1371/journal.pmed.0030263
Singh KR, Pavri KM (1967) Experimental studies with Chikungunya virus in Aedes aegypti and Aedes albopictus. Acta Virol 11(6):517–526
Souza-Neto JA, Sim S, Dimopoulos G (2009) An evolutionary conserved function of the JAK-STAT pathway in anti-dengue defense. Proc Natl Acad Sci U S A 106(42):17841–17846. https://doi.org/10.1073/pnas.0905006106
Steel JJ, Henderson BR, Lama SB, Olson KE, Geiss BJ (2011) Infectious alphavirus production from a simple plasmid transfection+. Virol J 8:356. https://doi.org/10.1186/1743-422X-8-356
Sun C, Gardner CL, Watson AM, Ryman KD, Klimstra WB (2014) Stable, high-level expression of reporter proteins from improved alphavirus expression vectors to track replication and dissemination during encephalitic and arthritogenic disease. J Virol 88(4):2035–2046. https://doi.org/10.1128/JVI.02990-13
Sy AK, Saito-Obata M, Medado IA, Tohma K, Dapat C, Segubre-Mercado E, Tandoc A 3rd, Lupisan S, Oshitani H (2016) Molecular characterization of Chikungunya virus, Philippines, 2011–2013. Emerg Infect Dis 22(5):887–890. https://doi.org/10.3201/eid2205.151268
Teng TS, Foo SS, Simamarta D, Lum FM, Teo TH, Lulla A, Yeo NK, Koh EG, Chow A, Leo YS, Merits A, Chin KC, Ng LF (2012) Viperin restricts Chikungunya virus replication and pathology. J Clin Invest 122(12):4447–4460. https://doi.org/10.1172/JCI63120
Teng TS, Kam YW, Lee B, Hapuarachchi HC, Wimal A, Ng LC, Ng LF (2015) A systematic meta-analysis of immune signatures in patients with acute Chikungunya virus infection. J Infect Dis 211(12):1925–1935. https://doi.org/10.1093/infdis/jiv049
Teo TH, Chan YH, Lee WW, Lum FM, Amrun SN, Her Z, Rajarethinam R, Merits A, Rotzschke O, Renia L, Ng LF (2017) Fingolimod treatment abrogates Chikungunya virus-induced arthralgia. Sci Transl Med 9(375). https://doi.org/10.1126/scitranslmed.aal1333
Teo TH, Lum FM, Claser C, Lulla V, Lulla A, Merits A, Renia L, Ng LF (2013) A pathogenic role for CD4 + T cells during Chikungunya virus infection in mice. J Immunol 190(1):259–269. https://doi.org/10.4049/jimmunol.1202177
Travanty EA, Adelman ZN, Franz AW, Keene KM, Beaty BJ, Blair CD, James AA, Olson KE (2004) Using RNA interference to develop dengue virus resistance in genetically modified Aedes aegypti. Insect Biochem Mol Biol 34(7):607–613. https://doi.org/10.1016/j.ibmb.2004.03.013
Tretyakova I, Hearn J, Wang E, Weaver S, Pushko P (2014) DNA vaccine initiates replication of live attenuated Chikungunya virus in vitro and elicits protective immune response in mice. J Infect Dis 209(12):1882–1890. https://doi.org/10.1093/infdis/jiu114
Tsetsarkin KA, McGee CE, Volk SM, Vanlandingham DL, Weaver SC, Higgs S (2009) Epistatic roles of E2 glycoprotein mutations in adaption of Chikungunya virus to Aedes albopictus and Aedes aegypti mosquitoes. PLoS One 4 (8):e6835. https://doi.org/10.1371/journal.pone.0006835
Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S (2007) A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3(12):e201. https://doi.org/10.1371/journal.ppat.0030201
Tsetsarkin KA, Weaver SC (2011) Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog 7(12):e1002412. https://doi.org/10.1371/journal.ppat.1002412
Utt A, Das PK, Varjak M, Lulla V, Lulla A, Merits A (2015) Mutations conferring a noncytotoxic phenotype on Chikungunya virus replicons compromise enzymatic properties of nonstructural protein 2. J Virol 89(6):3145–3162. https://doi.org/10.1128/JVI.03213-14
Utt A, Quirin T, Saul S, Hellstrom K, Ahola T, Merits A (2016) Versatile trans-replication systems for Chikungunya virus allow functional analysis and tagging of every replicase protein. PLoS ONE 11(3):e0151616. https://doi.org/10.1371/journal.pone.0151616
Van Bortel W, Dorleans F, Rosine J, Blateau A, Rousset D, Matheus S, Leparc-Goffart I, Flusin O, Prat C, Cesaire R, Najioullah F, Ardillon V, Balleydier E, Carvalho L, Lemaitre A, Noel H, Servas V, Six C, Zurbaran M, Leon L, Guinard A, van den Kerkhof J, Henry M, Fanoy E, Braks M, Reimerink J, Swaan C, Georges R, Brooks L, Freedman J, Sudre B, Zeller H (2014) Chikungunya outbreak in the Caribbean region, December 2013 to March 2014, and the significance for Europe. Euro Surveill 19(13)
Varghese FS, Thaa B, Amrun SN, Simarmata D, Rausalu K, Nyman TA, Merits A, McInerney GM, Ng LF, Ahola T (2016) The antiviral alkaloid berberine reduces Chikungunya virus-induced mitogen-activated protein kinase signaling. J Virol 90(21):9743–9757. https://doi.org/10.1128/JVI.01382-16
Vazeille M, Moutailler S, Coudrier D, Rousseaux C, Khun H, Huerre M, Thiria J, Dehecq JS, Fontenille D, Schuffenecker I, Despres P, Failloux AB (2007) Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito. Aedes albopictus. PLoS One 2(11):e1168. https://doi.org/10.1371/journal.pone.0001168
Waldock J, Olson KE, Christophides GK (2012) Anopheles gambiae antiviral immune response to systemic O’nyong-nyong infection. PLoS Negl Trop Dis 6(3):e1565. https://doi.org/10.1371/journal.pntd.0001565
Walker T, Jeffries CL, Mansfield KL, Johnson N (2014) Mosquito cell lines: history, isolation, availability and application to assess the threat of arboviral transmission in the United Kingdom. Parasit Vectors 7:382. https://doi.org/10.1186/1756-3305-7-382
Weaver SC, Forrester NL (2015) Chikungunya: Evolutionary history and recent epidemic spread. Antiviral Res 120:32–39. https://doi.org/10.1016/j.antiviral.2015.04.016
Weaver SC, Osorio JE, Livengood JA, Chen R, Stinchcomb DT (2012) Chikungunya virus and prospects for a vaccine. Expert Rev Vaccines 11(9):1087–1101. https://doi.org/10.1586/erv.12.84
Werneke SW, Schilte C, Rohatgi A, Monte KJ, Michault A, Arenzana-Seisdedos F, Vanlandingham DL, Higgs S, Fontanet A, Albert ML, Lenschow DJ (2011) ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. PLoS Pathog 7(10):e1002322. https://doi.org/10.1371/journal.ppat.1002322
Wielanek AC, Monredon JD, Amrani ME, Roger JC, Serveaux JP (2007) Guillain-Barre syndrome complicating a Chikungunya virus infection. Neurology 69(22):2105–2107. https://doi.org/10.1212/01.wnl.0000277267.07220.88
Xi Z, Ramirez JL, Dimopoulos G (2008) The Aedes aegypti toll pathway controls dengue virus infection. PLoS Pathog 4(7):e1000098. https://doi.org/10.1371/journal.ppat.1000098
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Carissimo, G., Ng, L.F.P. (2019). Understanding Molecular Pathogenesis with Chikungunya Virus Research Tools. In: Heise, M. (eds) Chikungunya Virus. Current Topics in Microbiology and Immunology, vol 435. Springer, Cham. https://doi.org/10.1007/82_2019_158
Download citation
DOI: https://doi.org/10.1007/82_2019_158
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-90609-2
Online ISBN: 978-3-030-90610-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)